Company Filing History:
Years Active: 2017
Title: Johanna Fink-Gremmels: Innovator in Mycotoxin Treatment
Introduction
Johanna Fink-Gremmels is a notable inventor based in Utrecht, Netherlands. She has made significant contributions to the field of mycotoxin exposure treatment. Her innovative work focuses on developing compositions that can alleviate conditions associated with mycotoxin exposure.
Latest Patents
Johanna holds a patent for the treatment of conditions associated with mycotoxin exposure. The patent describes a composition comprising a non-digestible oligosaccharide for the treatment, prevention, or alleviation of conditions related to trichothecene mycotoxin exposure. The non-digestible oligosaccharide may include galactooligosaccharides and/or fructooligosaccharides. Specifically, it may comprise short chain galacto-oligosaccharides (scGOS) and/or short chain fructooligosaccharides (scFOS). This invention is particularly relevant for conditions associated with exposure to deoxynivalenol.
Career Highlights
Johanna is associated with N.V. Nutricia, a company known for its focus on nutritional products. Her work at Nutricia has allowed her to explore innovative solutions in the field of health and nutrition.
Collaborations
Johanna has collaborated with notable colleagues, including Johan Garssen and Hermiena Christina Schoterman. These collaborations have contributed to her research and development efforts in addressing mycotoxin-related health issues.
Conclusion
Johanna Fink-Gremmels is a pioneering inventor whose work in mycotoxin treatment showcases her commitment to improving health outcomes. Her innovative patent reflects her expertise and dedication to addressing significant health challenges.